Novo Nordisk shares plunge 20% after disappointing trial results; Lilly jumps newsthirst.

Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. Hollie Adams | Reuters Shares of Danish pharmaceutical giant Novo Nordisk plummeted roughly 20% on Friday after reporting results in a late-stage trial for its experimental CagriSema weight loss drug that missed expectations. The maker of the wildly popular Wegovy obesity…

Read More

Cramer warns against day trading, calls zero-day options ‘pure greed’ newsthirst.

CNBC’s Jim Cramer on Friday warned novices against day trading, referencing an article from the Wall Street Journal that described how more investors are developing serious gambling addictions to risky market trading. “We need to help those who’re getting addicted, and we need to stop those who might become addicted,” he said. “After all, the…

Read More